Aurinia Pharmaceuticals
Company Information
Aurinia Pharmaceuticals is an Edmonton biopharmaceutical company focused on autoimmune diseases. Its commercial product is LUPKYNIS (voclosporin), and the company frames its mission around changing the trajectory of autoimmune disease, especially lupus nephritis. Aurinia’s science section also references pipeline work beyond LUPKYNIS, including aritinercept.
Industry Focus and Technologies
Autoimmune disease therapeutics, lupus nephritis, small molecule pharmaceuticals, clinical development, and commercial-stage biopharmaceuticals.
Location
Edmonton, Alberta, Canada
Company Size and Stage
Products, Platforms or Focus Areas
LUPKYNIS (voclosporin) for active lupus nephritis; autoimmune disease therapeutics; and pipeline programs including aritinercept.